HFBD: a biomarker knowledge database for heart failure heterogeneity and personalized applications
暂无分享,去创建一个
Bairong Shen | Yuxin Lin | Xingyun Liu | Rongrong Wu | Chaoying Zhan | Manhong Shi | Cheng Bi | Hongxin He | Shumin Ren | Hongxing He | Bairong Shen | Yuxin Lin | Manhong Shi | Rongrong Wu | Chaoying Zhan | Shumin Ren | Cheng Bi | Xingyun Liu | Bairong Shen
[1] Bairong Shen,et al. Physiological Informatics: Collection and Analyses of Data from Wearable Sensors and Smartphone for Healthcare. , 2017, Advances in experimental medicine and biology.
[2] Marc A Pfeffer,et al. Heart failure , 2005, The Lancet.
[3] Bairong Shen,et al. Computer-aided biomarker discovery for precision medicine: data resources, models and applications , 2019, Briefings Bioinform..
[4] Nick Freemantle,et al. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. , 2007, European heart journal.
[5] P. Zuchinali,et al. Causes and Predictors of In-Hospital Mortality in Patients Admitted with or for Heart Failure at a Tertiary Hospital in Brazil , 2017, Arquivos brasileiros de cardiologia.
[6] G R Sutherland,et al. Assessing diagnosis in heart failure: which features are any use? , 1997, QJM : monthly journal of the Association of Physicians.
[7] A. Mebazaa,et al. Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure , 2014, Circulation.
[8] Xin Qi,et al. Decoding competing endogenous RNA networks for cancer biomarker discovery , 2020, Briefings Bioinform..
[9] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[10] Bairong Shen,et al. Renyi Distribution Entropy Analysis of Short-Term Heart Rate Variability Signals and Its Application in Coronary Artery Disease Detection , 2019, Front. Physiol..
[11] A. Hoes,et al. Clinical epidemiology of heart failure , 2007, Heart.
[12] Bairong Shen,et al. CHDGKB: a knowledgebase for systematic understanding of genetic variations associated with non-syndromic congenital heart disease , 2020, Database J. Biol. Databases Curation.
[13] Jiajia Chen,et al. Deciphering oncogenic drivers: from single genes to integrated pathways , 2015, Briefings Bioinform..
[14] Hossam A. Hodeib,et al. Diagnostic and Prognostic Value of Plasma Levels of Cardiac Myosin Binding Protein-C as a Novel Biomarker in Heart Failure , 2017, Pediatric Cardiology.
[15] Hongxing He,et al. Early Detection of Sudden Cardiac Death by Using Ensemble Empirical Mode Decomposition-Based Entropy and Classical Linear Features From Heart Rate Variability Signals , 2020, Frontiers in Physiology.
[16] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[17] R. F. Kelly,et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. , 2002, The American journal of medicine.
[18] L. Lund. Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM. , 2018, Cardiac failure review.
[19] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[20] C. Fonseca,et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study , 2002, European journal of heart failure.
[21] T. Thenappan,et al. The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success? , 2014, Journal of the American College of Cardiology.
[22] Bairong Shen,et al. Translational Informatics for Parkinson’s Disease: from Big Biomedical Data to Small Actionable Alterations , 2019, Genom. Proteom. Bioinform..
[23] Bairong Shen,et al. Systems Health: A Transition from Disease Management Toward Health Promotion. , 2017, Advances in experimental medicine and biology.
[24] Bairong Shen,et al. CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer , 2020, Frontiers in Genetics.
[25] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[26] Chen Shao,et al. A Tool for Biomarker Discovery in the Urinary Proteome: A Manually Curated Human and Animal Urine Protein Biomarker Database* , 2011, Molecular & Cellular Proteomics.
[27] Danny Chuon,et al. Gastric Cancer (Biomarkers) Knowledgebase (GCBKB): A Curated and Fully Integrated Knowledgebase of Putative Biomarkers Related to Gastric Cancer , 2006, Biomarker insights.
[28] Bairong Shen,et al. Data-driven translational prostate cancer research: from biomarker discovery to clinical decision , 2020, Journal of Translational Medicine.
[29] A. Ferreira,et al. N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.
[30] G. Novo,et al. Biomarkers in heart failure. , 2009, Frontiers in bioscience.
[31] J. McMurray,et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology , 2009, European journal of heart failure.
[32] Bairong Shen,et al. Phenotype–genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs , 2020, Database J. Biol. Databases Curation.
[33] C. Lam,et al. The middle child in heart failure: heart failure with mid‐range ejection fraction (40–50%) , 2014, European journal of heart failure.
[34] C. Fonseca. Diagnosis of heart failure in primary care , 2006, Heart Failure Reviews.
[35] L. Lund. The Inescapable Heterogeneity of Heart Failure. , 2017, Journal of cardiac failure.
[36] D. Aarsland,et al. Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials , 2018, Movement disorders : official journal of the Movement Disorder Society.
[37] M. Woodward,et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial , 2017, Diabetes Care.
[38] Ying Wang,et al. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis , 2011, Comput. Biol. Chem..